Aims The pathogenesis of disease progression targets for patients with heart failure after
acute myocardial infarction was investigated by using plasma proteomics. Methods The …

Aims To provide insights into pathogenesis of disease progression and potential novel
treatment targets for patients with heart failure by investigation of the plasma proteome using …

Background Acute myocardial infarction (AMI) still has a high incidence of varying degrees
of heart failure (HF). The aim of this study is to identify new molecular markers for predicting …

Background: Heart failure (HF) is the most common long-term complication of acute
myocardial infarction (MI). Understanding plasma proteins associated with post-MI HF and …

Heart failure (HF) is a worldwide pandemic with an unacceptable high level of morbidity and
mortality. Understanding the different pathophysiological mechanisms will contribute to …

Background Cardiac rupture (CR) is a rare but catastrophic mechanical complication of
acute myocardial infarction (AMI) that seriously threatens human health. However, the …

The molecular differences between ischemic (IF) and non-ischemic (NIF) heart failure are
poorly defined. A better understanding of the molecular differences between these two heart …

Cardiac remodelling following myocardial infarction (MI) is a maladaptive change
associated with progressive heart failure and compromises long‐term clinical outcome. A …

The aim of the present study was to identify the mechanisms underlying the development of
post-myocardial infarction (post-MI) heart failure. The left anterior descending coronary …

Background: Post-infarction chronic heart failure is the most common type of heart failure.
Patients with chronic heart failure show elevated morbidity and mortality with limited …